Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
648.50 K
About Pelthos Therapeutics Inc.
Sector
Industry
CEO
Scott M. Plesha
Website
Headquarters
Durham
Founded
2021
FIGI
BBG01C9YP5V5
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PTHS is 21.99 USD — it has decreased by −0.05% in the past 24 hours. Watch Pelthos Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Pelthos Therapeutics Inc. stocks are traded under the ticker PTHS.
PTHS stock has risen by 1.01% compared to the previous week, the month change is a −81.36% fall, over the last year Pelthos Therapeutics Inc. has showed a −81.37% decrease.
We've gathered analysts' opinions on Pelthos Therapeutics Inc. future price: according to them, PTHS price has a max estimate of 60.00 USD and a min estimate of 60.00 USD. Watch PTHS chart and read a more detailed Pelthos Therapeutics Inc. stock forecast: see what analysts think of Pelthos Therapeutics Inc. and suggest that you do with its stocks.
PTHS reached its all-time high on Feb 16, 2024 with the price of 600.00 USD, and its all-time low was 12.30 USD and was reached on Jul 1, 2025. View more price dynamics on PTHS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PTHS stock is 6.28% volatile and has beta coefficient of 1.68. Track Pelthos Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Pelthos Therapeutics Inc. there?
Yes, you can track Pelthos Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Pelthos Therapeutics Inc. is going to release the next earnings report on Sep 3, 2025. Keep track of upcoming events with our Earnings Calendar.
No, PTHS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PTHS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pelthos Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pelthos Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pelthos Therapeutics Inc. stock shows the sell signal. See more of Pelthos Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.